|
1
|
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
|
J Crohns Colitis
|
2009
|
3.66
|
|
2
|
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis.
|
Am J Gastroenterol
|
2005
|
2.90
|
|
3
|
Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease.
|
Gastroenterology
|
2011
|
2.21
|
|
4
|
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.
|
Clin Gastroenterol Hepatol
|
2010
|
1.81
|
|
5
|
Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent.
|
Eur J Radiol
|
2007
|
1.77
|
|
6
|
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
|
J Crohns Colitis
|
2012
|
1.71
|
|
7
|
Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells.
|
FEMS Immunol Med Microbiol
|
2003
|
1.51
|
|
8
|
European evidence-based Consensus on the management of ulcerative colitis: Special situations.
|
J Crohns Colitis
|
2008
|
1.34
|
|
9
|
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease.
|
Gastroenterology
|
2007
|
1.24
|
|
10
|
Ileal pouchitis-related arthritis.
|
Semin Arthritis Rheum
|
2002
|
1.23
|
|
11
|
Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis.
|
Inflamm Bowel Dis
|
2010
|
1.11
|
|
12
|
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
|
Am J Gastroenterol
|
2005
|
1.11
|
|
13
|
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression.
|
Inflamm Bowel Dis
|
2005
|
1.06
|
|
14
|
Clinical guidelines for the management of pouchitis.
|
Inflamm Bowel Dis
|
2009
|
1.06
|
|
15
|
Attachment and quality of life in patients with inflammatory bowel disease.
|
Int J Colorectal Dis
|
2014
|
1.04
|
|
16
|
Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells.
|
World J Gastroenterol
|
2006
|
1.02
|
|
17
|
European evidence based consensus on surgery for ulcerative colitis.
|
J Crohns Colitis
|
2015
|
1.01
|
|
18
|
Adalimumab in active ulcerative colitis: a "real-life" observational study.
|
Dig Liver Dis
|
2013
|
0.98
|
|
19
|
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.
|
Dig Liver Dis
|
2010
|
0.95
|
|
20
|
Parental bonding and inflammatory bowel disease.
|
Psychosomatics
|
2010
|
0.93
|
|
21
|
Adult attachment and early parental experiences in patients with Crohn's disease.
|
Psychosomatics
|
2010
|
0.93
|
|
22
|
Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue.
|
World J Gastroenterol
|
2006
|
0.93
|
|
23
|
Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease.
|
Inflamm Bowel Dis
|
2007
|
0.91
|
|
24
|
Probiotic therapy to prevent pouchitis onset.
|
Dis Colon Rectum
|
2005
|
0.90
|
|
25
|
Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease.
|
J Clin Microbiol
|
2009
|
0.83
|
|
26
|
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy.
|
Intern Emerg Med
|
2011
|
0.82
|
|
27
|
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing.
|
Inflamm Bowel Dis
|
2010
|
0.81
|
|
28
|
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls.
|
J Behav Med
|
2012
|
0.81
|
|
29
|
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis.
|
World J Gastroenterol
|
2013
|
0.81
|
|
30
|
Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
|
Dermatology
|
2007
|
0.81
|
|
31
|
Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis.
|
Int J Antimicrob Agents
|
2008
|
0.80
|
|
32
|
Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism.
|
Inflamm Bowel Dis
|
2014
|
0.80
|
|
33
|
Sympathetic hyperactivity in patients with ulcerative colitis.
|
Clin Auton Res
|
2007
|
0.80
|
|
34
|
Clinical course of microscopic colitis in a single-center cohort study.
|
J Crohns Colitis
|
2011
|
0.80
|
|
35
|
Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach.
|
World J Gastroenterol
|
2010
|
0.79
|
|
36
|
Mucosal healing in pediatric Crohn's disease after anti-TNF therapy: a long-term experience at a single center.
|
Eur J Gastroenterol Hepatol
|
2014
|
0.78
|
|
37
|
Infliximab in the treatment of Crohn's disease.
|
Ther Clin Risk Manag
|
2007
|
0.78
|
|
38
|
CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue.
|
Int J Colorectal Dis
|
2003
|
0.77
|
|
39
|
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation?
|
Int J Colorectal Dis
|
2013
|
0.77
|
|
40
|
Rescue therapy: ciclosporin or infliximab?
|
Expert Rev Clin Immunol
|
2013
|
0.75
|
|
41
|
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease.
|
World J Gastroenterol
|
2011
|
0.75
|
|
42
|
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon.
|
Nanomedicine
|
2012
|
0.75
|
|
43
|
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease.
|
Pathology
|
2014
|
0.75
|